Cleared Special

K231293 - Drakon™ and Sequre® Microcatheters (FDA 510(k) Clearance)

Jun 2023
Decision
28d
Days
Class 2
Risk

K231293 is an FDA 510(k) clearance for the Drakon™ and Sequre® Microcatheters. This device is classified as a Catheter, Intravascular, Diagnostic (Class II - Special Controls, product code DQO).

Submitted by Accurate Medical Therapeutics (Rehovot, IL). The FDA issued a Cleared decision on June 1, 2023, 28 days after receiving the submission on May 4, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1200.

Submission Details

510(k) Number K231293 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 2023
Decision Date June 01, 2023
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQO - Catheter, Intravascular, Diagnostic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1200